Eptifibatide: Clinical Trials

14 trials of Eptifibatide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 terminated, 2 unknown. 14 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 214Completed 9, Terminated 3, Unknown 2
Phase 13Completed 1, Terminated 1, Unknown 1

Follow Eptifibatide: new trials by email Literature Review of Eptifibatide trials Research Report on Eptifibatide

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
Thrombolytic Agent - Acute Ischemic Stroke
Phase 1 / Phase 2UnknownBaylor College of Medicine302022-02-182022-06-10
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Ticagrelor, Eptifibatide, Clopidogrel - Acute Coronary Syndrome, Angina, Unstable
Phase 2CompletedUniversity of Alabama at Birmingham1002016-11-012020-05-04
Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion
Ticagrelor, Eptifibatide - Acute Coronary Syndrome
Phase 2CompletedUniversity of Alabama at Birmingham702014-02-012017-02-28
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)
Eptifibatide - Stroke, Brain Infarction
Phase 2CompletedArthur Pancioli272013-09-012016-01-21
Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
Ilomedin and Integrilin, low molecular weight heparin. - Pneumonia
Phase 2TerminatedThrombologic ApS52012-06-012016-04-22
Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Short Tirofiban, Eptifibatide, Long Tirofiban - Myocardial Infarction, Acute Coronary Syndromes
Phase 2CompletedMedicure5352012-04-012021-05-13
Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI Patients
Eptifibatide - Acute Myocardial Infarction
Phase 2UnknownAssaf-Harofeh Medical Center502009-08-012009-07-24
Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke
Eptifibatide, rt-PA - Ischemic Stroke, Stroke
Phase 2CompletedUniversity of Cincinnati1262009-07-012014-04-17
A Safety Study of Eptifibatide in Patients With Sickle Cell Disease
Eptifibatide, Placebo - Sickle Cell Disease
Phase 1 / Phase 2TerminatedUniversity of North Carolina, Chapel Hill132009-01-012013-06-27
A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart Attacks
eptifibatide, normal saline - ST-Elevation Myocardial Infarction
Phase 2TerminatedBrigham and Women's Hospital312007-11-012012-08-27
Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
Intravenous Glycoprotein inhibitor + ASA, Clopidogrel, Antiplatelet Therapy (ASA, Clopidogrel) - Stable Angina
Phase 2CompletedIcahn School of Medicine at Mount Sinai362007-04-012018-02-14
Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome
Otamixaban (XRP0673), unfractionated heparin, eptifibatide - Coronary Disease
Phase 2CompletedSanofi32412006-06-012014-12-03
Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
activase, integrilin - Stroke
Phase 1 / Phase 2CompletedUniversity of Cincinnati942003-07-012009-05-08
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
Aspirin, tinzaparin sodium, eptifibatide - Ischemic Stroke
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)182003-05-012013-02-04

Conditions studied

Ischemic Stroke (4)  ·  Acute Coronary Syndrome (3)  ·  Stroke (3)  ·  Angina, Unstable (2)  ·  Brain Infarction (2)  ·  Thrombosis (2)  ·  Anemia, Sickle Cell (1)  ·  Angina, Stable (1)  ·  Blushing (1)  ·  Coronary Disease (1)  ·  Death (1)  ·  Hemorrhage (1)  ·  Myocardial Infarction (1)  ·  Pneumonia (1)  ·  ST Elevation Myocardial Infarction (1)

Sponsors

University of Alabama at Birmingham (2)  ·  University of Cincinnati (2)  ·  Arthur Pancioli (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Baylor College of Medicine (1)  ·  Brigham and Women's Hospital (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Medicure (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Sanofi (1)  ·  Thrombologic ApS (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (12)  ·  Denmark (2)  ·  Finland (2)  ·  Israel (2)  ·  Argentina (1)  ·  Austria (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  France (1)

Top investigators

Massoud Leesar, MD (2)  ·  Annapoorna S Kini, MD MRCP (1)  ·  Arthur M Pancioli, MD (1)  ·  Arthur Pancioli, MD (1)  ·  C. Michael Gibson, M.D. (1)  ·  Eugene Braunwald, M.D. (1)  ·  Kenneth I Ataga, MD (1)  ·  Opeolu Adeoye, MD (1)  ·  Opeolu M Adeoye, MD (1)  ·  Steven V Manoukian, MD (1)  ·  Steven Warach, MD, PhD (1)

Results publications

PMID 19717184, PMID 23887841, PMID 23973010, PMID 26243231, PMID 28611098, PMID 31766977

NIH funding

P50NS044283 (1)